MTOR and hepatocellular carcinoma: CHE was reported to inhibit the proliferation of HCC cells and promote cell apoptosis, inhibiting metastasis and invasion of HCC in a dose-dependent manner by downregulating the expression of MMP-2/9 through the PI3K/Akt/mTOR pathway (Zhu et al., 2018).